PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32861877-0	2020	L-carnitine Extends the Telomere Length of the Cardiac Differentiated CD117+- Expressing Stem Cells.	Carnitine	0-11	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	70-75	
35546751-0	2022	L-carnitine reduced cellular aging of bone marrow resident C-kit+ hematopoietic stem cells through telomere dependent pathways.	Carnitine	0-11	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	59-64	
35546751-4	2022	This study aimed to evaluate the effects of L-carnitine (LC) on the aging of C-kit+ hematopoietic progenitor cells (HPCs) via examining the expression of some signaling pathway components.	Carnitine	57-59	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	77-82	
32861877-4	2020	Therefore, the present study was conducted to investigate the In -vitro effect of L-carnitine (LC) on the telomere length and human telomerase reverse transcriptase (hTERT) gene expression in the cardiac differentiated bone marrow resident CD117+ stem cells through Wnt3/beta-catenin and ERK1/2 pathways.	Carnitine	82-93	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	240-245	
32713855-0	2020	Cardiac differentiation of bone-marrow-resident c-kit+ stem cells by L-carnitine increases through secretion of VEGF, IL6, IGF-1, and TGF- beta as clinical agents in cardiac regeneration.	Carnitine	69-80	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	48-53	
32713855-5	2020	The aim of the present study was to investigate the in vitro effect of L-carnitine (LC) on cardiac differentiation of c-kit+ cells using a cytokines secretion assay.	Carnitine	71-82	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	118-123	
32713855-5	2020	The aim of the present study was to investigate the in vitro effect of L-carnitine (LC) on cardiac differentiation of c-kit+ cells using a cytokines secretion assay.	Carnitine	84-86	KIT proto-oncogene, receptor tyrosine kinase	Homo sapiens	118-123